Royalty Pharma plc
RPRX
$31.11
-$0.68-2.14%
RPRX market cap represents
0.32%
of the industry.
Valuation
RPRX
Low
RPRX
Industry Average
High
Market Cap
13.78B
< 3.55B
> 14.19B
Enterprise Value
23.80B
< 3.85B
> 23.80B
Price/Earnings (TTM)
17.62
< -10.00
> 20.00
Earnings Per Share Growth (TTM)
-28.88%
< -170.00%
> -20.00%
Price/Earnings To Growth (TTM)
--
0.00
12.75
Price/Sales (TTM)
8.27
0.00
> 750.00
Price/Book (Q)
2.04
< 0.00
> 30.00
Enterprise Value/Revenue (TTM)
10.51
< 10.00
> 330.00
Enterprise Value/EBITDA (TTM)
--
-356.26
4,375.79
Enterprise Value/EBIT (TTM)
18.41
< 0.00
> 20.00
Dividends and Shares
RPRX
Low
RPRX
Industry Average
High
Shares Outstanding
589.00M
< 60.00M
> 590.00M
Dividend Per Share (Most Recent)
0.22
0.00
2.38
Dividend Per Share (TTM)
0.85
0.00
9.13
Dividend Yield (TTM)
2.67%
0.00%
7.75%
Payout Ratio (TTM)
43.83
< 10.00
> 50.00
Price History
RPRX
Low
RPRX
Industry Average
High
Beta
0.26
< 0.00
6.09
1-Month Total Return
-4.59%
< -20.00%
> 0.00%
3-Month Total Return
24.28%
< -50.00%
> 30.00%
6-Month Total Return
16.27%
< -30.00%
> 20.00%
Year to Date Total Return
24.08%
< -40.00%
> 30.00%
1-Year Total Return
14.06%
< -20.00%
> 20.00%
2-Year Total Return
-5.52%
< -10.00%
> 30.00%
3-Year Total Return
-13.67%
< -30.00%
> 0.00%
5-Year Total Return
--
-100.00%
1,844.62%
Profitability
RPRX
Low
RPRX
Industry Average
High
Operating Margin (TTM)
57.09%
< -24,730.00%
> 60.00%
Profit Margin (TTM)
37.94%
< -18,830.00%
> 40.00%
Management Effectiveness
RPRX
Low
RPRX
Industry Average
High
Return on Assets (TTM)
4.67%
< -70.00%
> 10.00%
Return on Equity (TTM)
13.03%
< 10.00%
> 120.00%
Income Statement
RPRX
Low
RPRX
Industry Average
High
Revenue (TTM)
2.26B
< 1.07B
> 4.29B
Total Revenue (TTM)
2.26B
< 1.06B
> 4.28B
Total Revenue Growth (Q YOY)
-0.41%
< -10.00%
> 1,880.00%
Revenue Per Share (TTM)
3.84
0.00
> 230.00
Gross Profit (TTM)
1.53B
< 730.00M
> 2.96B
EBITDA (TTM)
--
-3.76B
29.94B
EBIT (TTM)
1.29B
< 120.00M
> 1.30B
Net Income (TTM)
858.98M
< 20.00M
> 860.00M
Net Income Avl. to Common (TTM)
858.98M
< 20.00M
> 860.00M
Earnings Growth (Q YOY)
-53.41%
< -60.00%
> 0.00%
EPS Diluted (TTM)
1.80
< -6,770.00
> 10.00
EPS Diluted Growth (Q YOY)
-68.08%
< -70.00%
> 180.00%
Balance Sheet
RPRX
Low
RPRX
Industry Average
High
Cash and Short-Term Inv. (Q)
987.23M
< 300.00M
> 1.23B
Cash Per Share (Q)
1.68
0.00
> 300.00
Total Current Assets (Q)
1.80B
< 600.00M
> 2.42B
Total Assets (Q)
18.22B
< 1.72B
> 18.23B
Total Current Liabilities (Q)
1.25B
< 350.00M
> 1.43B
Total Debt (Q)
7.61B
< 590.00M
> 7.62B
Total Liabilities (Q)
7.88B
< 1.03B
> 7.89B
Total Common Equity (Q)
6.95B
< 680.00M
> 6.95B
Total Preferred Equity (Q)
--
0.00
540.86M
Total Equity (Q)
10.34B
< 690.00M
> 10.35B
Current Ratio (Q)
1.438
0.086
> 20.000
Book Value Per Share (Q)
15.58
< 10.00
> 1,770.00
Cash Flow
RPRX
Low
RPRX
Industry Average
High
Cash from Operations (TTM)
2.77B
< 130.00M
> 2.77B
Cash from Investing (TTM)
-2.68B
< -2.68B
> -130.00M
Cash from Financing (TTM)
361.15M
< -110.00M
> 370.00M
Net Change in Cash (TTM)
452.02M
< -60.00M
> 460.00M
Levered Free Cash Flow (TTM)
-1.76B
< -1.76B
> 510.00M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
